Table 2.
Demographic and clinical characteristics of patients.
| References |
Sample size (Male/Female) |
Age (Treatment/Control) | Duration (month) (Treatment/Control) | Diagnostic criteria |
|---|---|---|---|---|
| Jiang (9) | 20 (8/12) | 24–62/– | 6–240/– | No mention |
| He et al. (16) | 11 (4/7) | 13–68/– | 6–168/– | Poser |
| Kang et al. (17) | 1 (0/1) | 25/– | 13/– | No mention |
| Hwang et al. (18) | 1 (0/1) | 55/– | 2/– | No mention |
| Heo et al. (19) | 1 (0/1) | 35/– | 33/– | McDonald |
| Jeon et al. (20) | 1 (0/1) | 38/– | 91/– | No mention |
| Zhou et al. (21) | 35 (No mention) | No mention | 43.36 ± 39.70/ 48.38 ± 40.52 |
McDonald |
| Liu et al. (22) | 43 (10/33) | 36.9 ± 12.2/– | 61.5 ± 62.1/– | Poser |
| Gao et al. (23) | 75 (27/48); Treatment group: 45 (13/32); Control group 30 (14/16) |
35.8 ± 11.7/ 36.4 ± 12.3 |
20.3 ± 6.7/– | Poser |
| Etemadifar et al. (24) | 52 (0/52); Treatment group: 26 (0/26); Control group: 26 (0/26) |
33.3 ± 7.5/34.5 ± 8.9 | 3.5 (1.5–5.5)/3.75 (1.15–6.25) | McDonald |
| Zhou et al. (25) | 67 (47/20); Treatment group: 43 (32/11); Control group: 24 (15/9) |
30.79 ± 9.78/ 36.54 ± 11.64 |
No mention | McDonald |